US3846243A - Automated analysis of oxidative metabolites - Google Patents

Automated analysis of oxidative metabolites Download PDF

Info

Publication number
US3846243A
US3846243A US00281908A US28190872A US3846243A US 3846243 A US3846243 A US 3846243A US 00281908 A US00281908 A US 00281908A US 28190872 A US28190872 A US 28190872A US 3846243 A US3846243 A US 3846243A
Authority
US
United States
Prior art keywords
stream
metabolite
protein
oxidative
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00281908A
Inventor
J Fletcher
R Furner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Aeronautics and Space Administration NASA
Original Assignee
National Aeronautics and Space Administration NASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Aeronautics and Space Administration NASA filed Critical National Aeronautics and Space Administration NASA
Priority to US00281908A priority Critical patent/US3846243A/en
Application granted granted Critical
Publication of US3846243A publication Critical patent/US3846243A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486Analgesics, e.g. opiates, aspirine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/200833Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/202499Formaldehyde or acetone

Definitions

  • Termination of the oxidative metabolism was accomplished by extracting the metabolite with an organic solvent.
  • the solvent also inactivated the oxidative enzymes.
  • the oxidative enzymes were first inactivated and precipitated by ZnSO an equimolar amount of Ba(OH) was used to precipitate the excess ZnSO and the mixture was centrifuged to remove the precipitated protein and the zinc and barium salts. An aliquot of the supernatant was then mixed with a special color forming reagent, commonly called Nash Reagent, and incubated for 30 minutes at 60 C. in order to assure maximum color development and maximum color stability.
  • a special color forming reagent commonly called Nash Reagent
  • the prior art method for measuring the formaldehyde had a number of inherently inconvenient and disadvantageous procedures; namely it required the use of heavy metals for the precipitation of proteins; it was time consuming, requiring about 1 /2 hours for a single sample; it required at least five individual transfers or additions of reagents; it required a water bath for incubation during the color forming phase, and close attention to the duration of the color forming phase. These numerous steps increase the potential for error.
  • the use of heavy metals is messy at best since special care is required in the cleaning of the analytical glassware.
  • an automated assay has been developed for the measurement of formaldehyde; the assay begins with sample constitution in the incubation stage and proceeds through the analysis by colorimetric techniques.
  • the problem of introducing pure oxygen into the system without distortion of the system was solved by using a Water gravity pump.
  • the flask containing oxygen is a closed system with a water head of 45-60 centimeters, so that a small but constant pressure can be maintained. Too much pressure could distort the system and disrupt the bubble pattern, overload the de-bubbler and ultimately cause pen noise.
  • the problem of determining the protein content in the incubation mixture was solved by splitting the sample after exit from the mixing coil and diverting a portion of the sample for automatic dilution and analysis by a modification of the Lowry method.
  • the present invention relates to a system for the automatic analysis of drug metabolites which consists of mixing the drug with an amount of enzyme and cofactor in the presence of 100% oxygen to form the metabolite, dialyzing the so-formed solution against phosphate bufier and developing color by adding a suitable reagent to the recipient stream of the dialysis.
  • FIG. 1 is a schematic flow diagram illustrating a novel system for automatically analyzing drug metabolites and protein content in incubation mixtures.
  • FIG. 2 is a side view of a water gravity pump for introducing 100% oxygen at a low, steady pressure into the automated system in FIG. 1.
  • FIG. 3 is a perspective view of a gravity fed cofactor dispensing system.
  • FIGS. 4A, 4B and 4C illustrate the dual pipette pickup assembly in action.
  • FIG. 4A shows the resting buffer pickup position.
  • FIG. 4B shows both pipettes raised out of the buffer.
  • FIG. 4C illustrates the enzyme-cofactor pickup position.
  • FIG. 5 is a plot of peaks in systems with and Without oxygen representing diffusion of oxygen from buffer into sample.
  • FIG. 6 is a perspective view of a solid aluminum sample plate.
  • the present invention relates to a procedure for monitoring the hepatic metabolites of aromatic amines such as aniline and compounds which form formaldehyde on oxidative dealkylation such as ethylmorphine and p-nitroanisole.
  • the system as shown schematically in FIG. 1 is first flushed with buffer which is introduced through pipettes 1 and 2 and with phenol solution through line 12 until it reaches equilibrium, normally about 30 minutes.
  • samples containing pg/ml. of freshly prepared p-aminophenol or formaldehyde in distilled Water (with or without protein) are introduced into the system via pipette 2 from a conventional sampler system 18, later described in detail.
  • the complete incubation mixture was previously prepared in an ice bath near 0 C. and placed in sample cups on the sample plate 18A a few minutes before sample pickup. The preparation and constitution of the incubation mixture for the developmental phase is described next.
  • the rat liver homogenate used in the incubation mixture was prepared by placing five grams of rat liver in a vessel containing 10 ml. 1.15% KCl and homogenized for 30 seconds with a conventional homogenizer. The homogenate was then centrifuged for 20 minutes at 9,000 gravity and the supernatant decanted. This supernatant was used as the source of enzyme, and after dilution, each ml. contained the soluble portion of 333 mg. whole liver or 333mg. whole liver equivalents (WLE). It was maintained on ice until used.
  • the cofactor-substrate solution contained: 4.0/L moles NADP, 500 moles glucose6-phospate, 20.0,u. moles nicotinamide, 25.0,u. moles MgCl 10.0,u moles aniline-HCI or 5.0;1. moles ethylmorphine-HCl.
  • the above was made up to 4.0 ml. with 0.1 M phosphate buifer. If the substrate was p-nitroanisole, the volume was 3.9 ml. and 10.0,u moles p-nitroanisole in 0.1 ml. acetone was added.
  • the incubation mixture was made by mixing 4.0 ml. of the cofactor-substrate solution (3.9 ml. when p-nitroanisole was the substrate) with 1.0 ml. of the homogenate supernatant. Tissue concentration was 67 mg./ml. in terms of while liver. Approximately 1.5 ml. of the incubation mixture was placed in a 2.0 ml. sample cup, and the cup placed on the turntable of a sample changer. The remaining portion of the mixture was kept on ice until the next sample was to be inserted. Following this procedure, there was less than 1% transmission difference between duplicates or triplicates of the same sample.
  • the cofactor-substrate part of the sample is picked up in line 1 of the sample pickup system 18 from a specially designed trough supplied by a feed mechanism as is later described in detail in conjunction with FIG. 4.
  • the enzyme is picked up by the second line 2 from the sampler system 18.
  • the two parts of the sample pass over the platen of the proportion pump in the ratio 4225:1225 cofactor-substrate to enzyme respectively and then pass through a mixing coil 3 to assure homogeneity.
  • the sample After exiting from the mixing coil 3 the sample is split. One portion of the sample, equal to the original volume of the enzyme alone, is reacted with Lowrys reagents to colorimetrically determine the protein content. The remaining portion enters the water bath 6 Where incubation occurs. The protein analysis is described first.
  • the protein analysis sample is diverted through line 4, automatically diluted approximately times with phosphate bufier from source 4A and mixed in coil 19 (30 turns). A portion of this sample is aerated at 20 and reacted with Lowrys reagents in two steps, the remaining portion going to waste.
  • the first step consists of reaction with a solution containing 0.02% CuSO 0.04% sodium potassium tartrate and 2% Na CO in a solution which is 0.1 N with NaOH from source 20A followed by mixing in coil 21 (24 turns).
  • the sample is reacted with phenol-ciocalteu-water 1:6 from line 12, passed through the reaction coil 22 (84 turns) and the colored solution is moved on the colorimeter 28 with 660 m filters, Where the air bubbles are removed by exhaust action of the proportioning pump 13 and the colored material is forced through a flow cell with a 1.5 cm. light path. Percent transmittance is measured by a photomultiplier tube and recorded on a strip chart 14.
  • the remaining portion of the original sample, after the portion for protein analysis has been diverted, is oxygenated from line 5 by bubbling in 100% oxygen from the water gravity pump later described in detail in FIG. 2.
  • the oxygen separates the sample into segments, facilitates mixing, helps to eliminate deposit formation in the lines, and insures uniform reaction of the sample with enzyme.
  • Oxygen to sample ratio is about 0.31 by volume.
  • the oxygenated sample moves into an incubation coil in water bath 6 maintained at 37 C. Time in the coil is about 10.5 minutes (time depends upon coil length and flow rate). During the period the substrate is metabolized the oxygenated sample containing the metabolite is forced through the continuous flow dialyzer 7 maintained at 25 C. and equipped with a standard membrane.
  • Dialysis is against oxygenated buffer provided by lines 8 and 9 with a flow rate identical to the oxygenated sample.
  • the metabolite dialyzes across the membrane is carried out of the dialyzer by the bulfer.
  • the dialyzed sample containing protein exits to Waste via line 11.
  • the dialysate containing the metabolite is reacted with a suitable color forming reagent provided by line 12 and the mixture allowed to incubate for approximately 6 minutes in reaction coil 10 and 1 minute in coil 17.
  • the color forming reagent is selected according to the metabolite being analyzed.
  • p-Aminophenol requires IN- NaOH containing 5% phenol to form -a blue color at room temperature with an absorption maximum near 620 mp
  • formaldehyde requires a reagent prepared as follows: gm. ammonium acetate, 3 ml. glacial acetic acid, 2 ml. acetylacetone diluted to 400 ml. with distilled water.
  • this reagent yields a bright yellow color with an absorption maximum near 412 ru
  • the color forming coils 10 are placed in a water bath at 60 C. Time for color formation is about 6 minutes.
  • the colored material is passed through the air-cooled coil 17 before proceeding to a de-bubbler and the flow cell in the colorimeter 24. Cooling prevents overloading the de-bubbler by contracting the gas bubble. Percent transmittance is measured by a photomultiplier tube and recorded on a strip chart recorder 14. Concentration of the metabolite is proportional to the log of the peak height.
  • FIG. 2 there is shown a method for introducing oxygen into the system without distortion of bubble patterns.
  • This consists of a water gravity pump having a flask 2A with the flask about half filled with water and with pure oxygen standing over the water. Additional water can now be introduced by siphon action from flask 2B so that oxygen from flask 2A is forced out through the lines 5 and 9. In this way a very gentle but controlled positive pressure can be maintained on the oxygen lines so that bubbles are introduced into the system in a regular and uniform fashion.
  • FIG. 3 illustrates a gravity fed dispenser for cofactorsubstrate which feeds into the dual pipette pickup assembly shown in FIGS. 4A, B and C, both of which are at the sample pickup location 18 in FIG. 1.
  • Cofactorsubstrate solution is placed in the 1000 ml. container 25 equipped with a stop-cock 26 for passage of liquid, a stop-cock 27 in the internal pressure equilibration arm, an air tight stopper 23 and a 4-inch delivery barrel 29. After the delivery barrel 29 is placed in opening 30 (FIG. 4) and allowed to rest on the ledge 31, the stopcocks 26 and 27 are opened allowing cofactor-substrate solution to spill into trough 32.
  • Pipette 1 is in a continual exhaust state and therefore it must be in liquid to avoid introduction of air bubbles into the system. When it is not in the cofactor-substrate trough 32, it is in the buffer trough 34.
  • Pipette 2 is in buffer trough 35 or in a sample cup 18A in the sample changer. Buffer is presented to trough 34 by inflow line 16. Excess buffer overflows into spillover chamber 36 and hence through the waste exit 37.
  • the butler supply 16A to trough 35 is standard on existing equipment and is partially obscured by the cofactor substrate-butfer reservoir.
  • FIGS. 4A, 4B and 4C show the successive stages of the movements of the two pipettes.
  • the sample plate 33 (see also FIG. 6) is made of solid aluminum for high thermal conductivity.
  • the center well 33A of the aluminum plate is deep enough to accept ice, frozen CO or other material to maintain a desirable temperature in the sample cup 18A.
  • the solutions in the sample cup are maintained between 0.5 and 1.5 C.
  • a microswitch lever on the sample changer is bent so that the sample plate turns freely until a stop pin in a stop pin hole 38 engages the microswitch lever and interrupts the cycle.
  • FIG. 5 shows the results obtained with oxygen and without oxygen.
  • the broken line shows the result without oxygen wherein the oxidative metabolism of aniline appeared as small twin peaks.
  • the system did not respond to increased cofactor concentrations or increased tissue concentrations.
  • the peaks coincide with sample extremities, so it was reasoned that the buffer might have contributed to metabolism by permitting some factor to diffuse out or permitting another factor to difluse in. It was found that this difliculty could be solved by adding 100% oxygen to the system to replace the standard air bubbles and,
  • a method for the continuous-flow analysis of oxidative metabolites of aromatic amines and of compounds which produce formaldehyde on oxidative dealkylation consisting essentially of the steps of:
  • the substrate consists essentially of materials selected from ethylmorphine and p-nitroanisole.
  • the metabolite color forming reagent consists essentialy of g. ammonium acetate, 3 m1. glacial acetic acid, and 2 m1. acetylacetone in 400 ml. distilled water.
  • the color forming reagent for protein consists essentially of a solution containing .02% CuSO 04% sodium potassium tartrate, and 2% Na CO and which is 0.1 N with NAOH mixed with a phenol-ciocalteu-water solution in the ratio of 1:6.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

1. A METHOD FOR CONTINUOUS-FLOW ANALYSIS OF OXIDATIVE METABOLITES OF AROMATIC AMINES AND OF COMPOUNDS WHICH PRODUCE FORMALDEHYDE ON OXIDATIVE DEALKYLATION CONSISTING ESSENTIALLY OF THE STEPS OF: (1) COMBINING A FLUID STREAM COMPRISING A SUBSTRATECOFACTOR A PHOSPHATE BUFFER WITH A RAT LIVER HOMOGENATE COMPRISING OXIDATIVE MICROSOMAL ENZYMES, (2) DIVIDING THE RESULTING MIXTURE INTO A FIRST STREAM FOR DETERMING THE QUANTITY OF PROTEIN AND INTO A SECOND STREAM FOR METABOLIZING THE SUBSTRATE AND FOR DETERMINING THE QUANTITY OF METALBOLITE GENERATED DURING SUCH METABOLISM, (3) DILUTING SAID FIRST STREAM WITH PHOSPHATE BUFFER, (4) AERATING SAID DILUTED FIRST STREAM, (5) REACTING SAID AERATED FIRST STREAM WITH A COLOR FORMING REAGENT FOR PROTEIN, (6) COLORIMETRICALLY DETERMINING THE AMOUNT OF PROTEIN, (7) INTERMITTENTLY ADDING SMALL ALIQUOTS OF 100% OXYGEN TO SAID SECOND STREAM, (8) INCUBATING SAID OXYGENATED SECOND STREAM AT A CONTROLLED TEMPERATURE TO PROMOTE THE FORMATION OF METABOLITE BY ENZYME ACTION ON SAID SUBSTRATE, (9) DIALYZING SAID SECOND STREAM AGAINST PHOSPHATE BUFFER, AND (10) COLORIMETRICALLY DETERMINING THE CONCENTRATION OF METABOLITE AFTER REACTING THE DIALSATE WITH A COLOR FORMING REAGENT FOR SAID METABOLITE.

Description

Nov. 5, 1974 JAMES C. FLETCHER ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION AUTOMATED ANALYSIS OF OXIDATIVE METABOLITES Filed Aug. 18, 1972 4 Sheets-Sheet 1 )3 [28 22 coLgglgETfik 1W4 f ,2 CI gSfI E II-W D FINE;
2| .0Z% M504 1 og'x zlal mkmArE 14 v v 20 ollwfiaofi RECORDER WASTE I m 03 -0 v T fl9 4 COLOKIMETEK PIgOSPHATE Q1??? 16 g m 4 pH 7.4. A 3 24 [/8- 3 SAMPLE [7 M1107: [J PICK-UP DIALVZEK WATEK I 25 5 91 I OXYGEN 4 COLOR =1 FDKMING REAGENT PKOPOKTIONING PUMP Nov. 5, 1914 3,846,243
ADMINISTRATOR OF THE'NATIONAL AERONAUTICS JAME C. FLETCHER AND SPACE ADMINISTRATION. AUTOMATED ANALYSIS OF OXIDATIVE IE'I'ABOLITBS Filed Aug. 18, 1972 4 Sheets-Sheet 2 Nov. 5, 1974 JAMES c. FLETCHER 34 ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION AUTOIATED ANALYSIS OF DXIDATIVE IBTABOLITIS Filed Aug. 18, 1972 4' Sheets-Sheet 5 U.S. Cl. 195103.5 R 6 Claims ABSTRACT OF THE DISCLOSURE An automated system for the study of drug metabolism is disclosed. The system monitors the oxidative metabolites of aromatic amines and of compounds which produce formaldehyde on oxidative dealkylation. It includes color developing compositions suitable for detecting hydroxylated aromatic amines and formaldehyde.
The invention described herein was made by a Research Associate of National Academy of Sciences while under contract with the United States Government and may be manufactured and used by or for the Government for governmental purposes without the payment of any royalties thereon or therefor.
BACKGROUND OF THE INVENTION Field of the invention An automated system for the study of drug metabolism.
Description of the prior art The metabolism of aniline to p-aminophenol by oxidative microsomal enzymes has been studied in considerable detail by numerous investigators. Previous methods for studying oxidative metabolism required that the enzyme, substrate and cofactors be mixed in a flask and placed in a constant temperature water bath for incubation. Time of incubation was generally an arbitrary unit varying from minutes to an hour or more depending on the substrate.
Termination of the oxidative metabolism was accomplished by extracting the metabolite with an organic solvent. The solvent also inactivated the oxidative enzymes.
An aliquot of the organic solvent was transferred to another vessel containing an alkaline mixture containing phenol. The metabolite was then re-extracted into the alkaline medium containing phenol to form a blue color with an absorption maximum near 620 m Although this extraction procedure has been made more sensitive by increasing the phenol concentration in the alkaline extraction medium, it has certain inherent inconveniences and disadvantages; namely, it requires an ether extraction; it is time consuming (1 /2 hours for a single sample) and it requires at least four individual transfers or additions of reagent. These numerous steps increase the potential for error. Working with organic solvents is both hazardous and unpleasant.
With these points in mind an assay for the oxidative metabolism of aniline has been automated from the incu bation stage through quantitative analysis by color formation of the metabolite, p-aminophenol.
To measure the formation of formaldehyde from substrates which are oxidatively N-demethylated or O-de methylated, the oxidative enzymes were first inactivated and precipitated by ZnSO an equimolar amount of Ba(OH) was used to precipitate the excess ZnSO and the mixture was centrifuged to remove the precipitated protein and the zinc and barium salts. An aliquot of the supernatant was then mixed with a special color forming reagent, commonly called Nash Reagent, and incubated for 30 minutes at 60 C. in order to assure maximum color development and maximum color stability. The
United States Patent 0 3,846,243 Patented Nov. 5, 1974 colored mixture had an absorption maximum near 412 Inn.
The prior art method for measuring the formaldehyde had a number of inherently inconvenient and disadvantageous procedures; namely it required the use of heavy metals for the precipitation of proteins; it was time consuming, requiring about 1 /2 hours for a single sample; it required at least five individual transfers or additions of reagents; it required a water bath for incubation during the color forming phase, and close attention to the duration of the color forming phase. These numerous steps increase the potential for error. The use of heavy metals is messy at best since special care is required in the cleaning of the analytical glassware.
Following a similar procedure to that described herein for the measurement of p-aminophenol, an automated assay has been developed for the measurement of formaldehyde; the assay begins with sample constitution in the incubation stage and proceeds through the analysis by colorimetric techniques.
In these analyses dialysis has replaced ether extraction and protein precipitation; transfer steps have been completely eliminated; a method for using a minimal amount of valuable cofactor has been provided; an aluminum sample plate has been devised that keeps the enzyme suspension cold until analysis actually is begun; the time between the start of incubation and recording of results has been made uniform; time required for one analysis has been reduced to 20 minutes plus 2 minutes for each additional sample or duplicate. A multiplicity of operations can be performed inexpensively, accurately, with a high degree of reproducibility and with the results automatically recorded while the analyses are being performed.
Initially, the product of the oxidative metabolism of aniline appeared as small dual peaks (FIG. 6), even though successful recovery of p-aminophenol as a single peak had been achieved. The system did not respond to increased cofactor concentrations or increased protein concentrations. The possibility that one of the peaks might represent color formed from 0- or m-aminophenol was investigated and found negative. The enzymes were simply not metabilizing aniline to p-aminophenol except at the ends of the sample.
The peaks coincided with the sample extremities, and so it was reasoned that lack of suflicient oxygen might be responsible for reduced metabolism in the middle portion of the sample. The replacement of air bubbles with oxygen, using an oxygen to sample ratio of 0.31 by volume yielded symmetrical, reproducible peaks.
The problem of introducing pure oxygen into the system without distortion of the system was solved by using a Water gravity pump. The flask containing oxygen is a closed system with a water head of 45-60 centimeters, so that a small but constant pressure can be maintained. Too much pressure could distort the system and disrupt the bubble pattern, overload the de-bubbler and ultimately cause pen noise.
The problem of determining the protein content in the incubation mixture was solved by splitting the sample after exit from the mixing coil and diverting a portion of the sample for automatic dilution and analysis by a modification of the Lowry method.
SUMMARY OF THE INVENTION The present invention relates to a system for the automatic analysis of drug metabolites which consists of mixing the drug with an amount of enzyme and cofactor in the presence of 100% oxygen to form the metabolite, dialyzing the so-formed solution against phosphate bufier and developing color by adding a suitable reagent to the recipient stream of the dialysis.
3 BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic flow diagram illustrating a novel system for automatically analyzing drug metabolites and protein content in incubation mixtures.
FIG. 2 is a side view of a water gravity pump for introducing 100% oxygen at a low, steady pressure into the automated system in FIG. 1.
FIG. 3 is a perspective view of a gravity fed cofactor dispensing system.
FIGS. 4A, 4B and 4C illustrate the dual pipette pickup assembly in action. FIG. 4A shows the resting buffer pickup position. FIG. 4B shows both pipettes raised out of the buffer. FIG. 4C illustrates the enzyme-cofactor pickup position.
FIG. 5 is a plot of peaks in systems with and Without oxygen representing diffusion of oxygen from buffer into sample.
FIG. 6 is a perspective view of a solid aluminum sample plate.
DESCRIPTION OF THE PREFERRED EMBODIMENT The present invention relates to a procedure for monitoring the hepatic metabolites of aromatic amines such as aniline and compounds which form formaldehyde on oxidative dealkylation such as ethylmorphine and p-nitroanisole.
The system as shown schematically in FIG. 1 is first flushed with buffer which is introduced through pipettes 1 and 2 and with phenol solution through line 12 until it reaches equilibrium, normally about 30 minutes. To calibrate the system, samples containing pg/ml. of freshly prepared p-aminophenol or formaldehyde in distilled Water (with or without protein) are introduced into the system via pipette 2 from a conventional sampler system 18, later described in detail. In the initial phase of development when metabolism was studied the complete incubation mixture was previously prepared in an ice bath near 0 C. and placed in sample cups on the sample plate 18A a few minutes before sample pickup. The preparation and constitution of the incubation mixture for the developmental phase is described next.
The rat liver homogenate used in the incubation mixture -was prepared by placing five grams of rat liver in a vessel containing 10 ml. 1.15% KCl and homogenized for 30 seconds with a conventional homogenizer. The homogenate was then centrifuged for 20 minutes at 9,000 gravity and the supernatant decanted. This supernatant was used as the source of enzyme, and after dilution, each ml. contained the soluble portion of 333 mg. whole liver or 333mg. whole liver equivalents (WLE). It was maintained on ice until used.
The cofactor-substrate solution contained: 4.0/L moles NADP, 500 moles glucose6-phospate, 20.0,u. moles nicotinamide, 25.0,u. moles MgCl 10.0,u moles aniline-HCI or 5.0;1. moles ethylmorphine-HCl. The above was made up to 4.0 ml. with 0.1 M phosphate buifer. If the substrate was p-nitroanisole, the volume was 3.9 ml. and 10.0,u moles p-nitroanisole in 0.1 ml. acetone was added.
The incubation mixture was made by mixing 4.0 ml. of the cofactor-substrate solution (3.9 ml. when p-nitroanisole was the substrate) with 1.0 ml. of the homogenate supernatant. Tissue concentration was 67 mg./ml. in terms of while liver. Approximately 1.5 ml. of the incubation mixture was placed in a 2.0 ml. sample cup, and the cup placed on the turntable of a sample changer. The remaining portion of the mixture was kept on ice until the next sample was to be inserted. Following this procedure, there was less than 1% transmission difference between duplicates or triplicates of the same sample.
In the preferred procedure, after equilibrating the system in FIG. 1, as described above, the cofactor-substrate part of the sample is picked up in line 1 of the sample pickup system 18 from a specially designed trough supplied by a feed mechanism as is later described in detail in conjunction with FIG. 4. The enzyme is picked up by the second line 2 from the sampler system 18. The two parts of the sample pass over the platen of the proportion pump in the ratio 4225:1225 cofactor-substrate to enzyme respectively and then pass through a mixing coil 3 to assure homogeneity.
After exiting from the mixing coil 3 the sample is split. One portion of the sample, equal to the original volume of the enzyme alone, is reacted with Lowrys reagents to colorimetrically determine the protein content. The remaining portion enters the water bath 6 Where incubation occurs. The protein analysis is described first.
The protein analysis sample is diverted through line 4, automatically diluted approximately times with phosphate bufier from source 4A and mixed in coil 19 (30 turns). A portion of this sample is aerated at 20 and reacted with Lowrys reagents in two steps, the remaining portion going to waste. The first step consists of reaction with a solution containing 0.02% CuSO 0.04% sodium potassium tartrate and 2% Na CO in a solution which is 0.1 N with NaOH from source 20A followed by mixing in coil 21 (24 turns). In the second step the sample is reacted with phenol-ciocalteu-water 1:6 from line 12, passed through the reaction coil 22 (84 turns) and the colored solution is moved on the colorimeter 28 with 660 m filters, Where the air bubbles are removed by exhaust action of the proportioning pump 13 and the colored material is forced through a flow cell with a 1.5 cm. light path. Percent transmittance is measured by a photomultiplier tube and recorded on a strip chart 14.
The remaining portion of the original sample, after the portion for protein analysis has been diverted, is oxygenated from line 5 by bubbling in 100% oxygen from the water gravity pump later described in detail in FIG. 2. The oxygen separates the sample into segments, facilitates mixing, helps to eliminate deposit formation in the lines, and insures uniform reaction of the sample with enzyme. Oxygen to sample ratio is about 0.31 by volume.
The oxygenated sample moves into an incubation coil in water bath 6 maintained at 37 C. Time in the coil is about 10.5 minutes (time depends upon coil length and flow rate). During the period the substrate is metabolized the oxygenated sample containing the metabolite is forced through the continuous flow dialyzer 7 maintained at 25 C. and equipped with a standard membrane.
Dialysis is against oxygenated buffer provided by lines 8 and 9 with a flow rate identical to the oxygenated sample. The metabolite dialyzes across the membrane is carried out of the dialyzer by the bulfer. The dialyzed sample containing protein exits to Waste via line 11. The dialysate containing the metabolite is reacted with a suitable color forming reagent provided by line 12 and the mixture allowed to incubate for approximately 6 minutes in reaction coil 10 and 1 minute in coil 17.
The color forming reagent is selected according to the metabolite being analyzed. p-Aminophenol requires IN- NaOH containing 5% phenol to form -a blue color at room temperature with an absorption maximum near 620 mp, while formaldehyde requires a reagent prepared as follows: gm. ammonium acetate, 3 ml. glacial acetic acid, 2 ml. acetylacetone diluted to 400 ml. with distilled water. When combined with formaldehyde this reagent yields a bright yellow color with an absorption maximum near 412 ru In the analysis of formaldehyde the color forming coils 10 are placed in a water bath at 60 C. Time for color formation is about 6 minutes. After the heating bath the colored material is passed through the air-cooled coil 17 before proceeding to a de-bubbler and the flow cell in the colorimeter 24. Cooling prevents overloading the de-bubbler by contracting the gas bubble. Percent transmittance is measured by a photomultiplier tube and recorded on a strip chart recorder 14. Concentration of the metabolite is proportional to the log of the peak height.
In FIG. 2 there is shown a method for introducing oxygen into the system without distortion of bubble patterns. This consists of a water gravity pump having a flask 2A with the flask about half filled with water and with pure oxygen standing over the water. Additional water can now be introduced by siphon action from flask 2B so that oxygen from flask 2A is forced out through the lines 5 and 9. In this way a very gentle but controlled positive pressure can be maintained on the oxygen lines so that bubbles are introduced into the system in a regular and uniform fashion.
FIG. 3 illustrates a gravity fed dispenser for cofactorsubstrate which feeds into the dual pipette pickup assembly shown in FIGS. 4A, B and C, both of which are at the sample pickup location 18 in FIG. 1. Cofactorsubstrate solution is placed in the 1000 ml. container 25 equipped with a stop-cock 26 for passage of liquid, a stop-cock 27 in the internal pressure equilibration arm, an air tight stopper 23 and a 4-inch delivery barrel 29. After the delivery barrel 29 is placed in opening 30 (FIG. 4) and allowed to rest on the ledge 31, the stopcocks 26 and 27 are opened allowing cofactor-substrate solution to spill into trough 32. As the level of liquid rises an equilibrium of hydrostatic pressure is reached which prevents further flow from 25 until the liquid level is decreased by withdrawal through pipette 1. Thus, the reservoir is continually refilled, but does not overflow; the cofactor-substrate is used only for each sample and is not continuously introduced into the system.
Pipette 1 is in a continual exhaust state and therefore it must be in liquid to avoid introduction of air bubbles into the system. When it is not in the cofactor-substrate trough 32, it is in the buffer trough 34.
Pipette 2 is in buffer trough 35 or in a sample cup 18A in the sample changer. Buffer is presented to trough 34 by inflow line 16. Excess buffer overflows into spillover chamber 36 and hence through the waste exit 37. The butler supply 16A to trough 35 is standard on existing equipment and is partially obscured by the cofactor substrate-butfer reservoir.
The sequence of steps is clearly shown in FIGS. 4A, 4B and 4C which show the successive stages of the movements of the two pipettes.
The sample plate 33 (see also FIG. 6) is made of solid aluminum for high thermal conductivity. The center well 33A of the aluminum plate is deep enough to accept ice, frozen CO or other material to maintain a desirable temperature in the sample cup 18A. When cooled with ice, the solutions in the sample cup are maintained between 0.5 and 1.5 C. A microswitch lever on the sample changer is bent so that the sample plate turns freely until a stop pin in a stop pin hole 38 engages the microswitch lever and interrupts the cycle.
FIG. 5 shows the results obtained with oxygen and without oxygen. The broken line shows the result without oxygen wherein the oxidative metabolism of aniline appeared as small twin peaks. The system did not respond to increased cofactor concentrations or increased tissue concentrations. The peaks coincide with sample extremities, so it was reasoned that the buffer might have contributed to metabolism by permitting some factor to diffuse out or permitting another factor to difluse in. It was found that this difliculty could be solved by adding 100% oxygen to the system to replace the standard air bubbles and,
as the solid line shows, a single sharp peak is achieved by the addition of oxygen. The method of adding the oxygen without distorting the bubble pattern of the system was previously described in conjunction with FIG. 2.
While I have illustrated a preferred mode of practicing the present invention, it will be understood that the invention may be practiced otherwise than illustrated here. Various changes may be made and will occur to those skilled in the art without departing from the underlying idea of this invention within the scope of the appended claims.
I claim:
1. A method for the continuous-flow analysis of oxidative metabolites of aromatic amines and of compounds which produce formaldehyde on oxidative dealkylation consisting essentially of the steps of:
(l) combining a fluid stream comprising a substratecofactor in a phosphate buffer with a rat liver homogenate comprising oxidative microsomal enzymes,
(2) dividing the resulting mixture into a first stream for determining the quantity of protein and into a second stream for metabolizing the substrate and for determining the quantity of metabolite generated during such metabolism,
(3) diluting said first stream with phosphate bufl er,
(4) aerating said diluted first stream,
(5 reacting said aerated first stream with a color forming reagent for protein,
(6) colorimetrically determining the amount of protein,
(7) intermittently adding small aliquots of oxygen to said second stream,
(8) incubating said oxygenated second stream at a controlled temperature to promote the formation of metabolite by enzyme action on said substrate,
(9) dialyzing said second stream against phosphate buffer, and
(10) colorimetrically determining the concentration of metabolite after reacting the dialysate with a color forming reagent for said metabolite.
2. The method of claim 1 wherein said substrate consists essentially of aniline.
3. The method of claim 2 wherein the metabolite color forming reagent is 1 normal NaOH containing 5% phenol.
4. The method of claim 1 wherein the substrate consists essentially of materials selected from ethylmorphine and p-nitroanisole.
5. The method of claim 4 wherein the metabolite color forming reagent consists essentialy of g. ammonium acetate, 3 m1. glacial acetic acid, and 2 m1. acetylacetone in 400 ml. distilled water.
6. The method of claim 1 wherein the color forming reagent for protein consists essentially of a solution containing .02% CuSO 04% sodium potassium tartrate, and 2% Na CO and which is 0.1 N with NAOH mixed with a phenol-ciocalteu-water solution in the ratio of 1:6.
References Cited UNITED STATES PATENTS 3,699,004 10/1972 Skeggs -103.5 R 2,897,058 7/1959 Galat 23230 B 3,310,382 3/1967 Kingsley 23--230 B OTHER REFERENCES Nash, T.: The Colorimetric Estimation of Formaldehyde by Means of the Hantzsch Reaction, Biochem. 1., vol. 55, 1953 (pp. 416-421).
DAVID M. NAFF, Primary Examiner

Claims (1)

1. A METHOD FOR CONTINUOUS-FLOW ANALYSIS OF OXIDATIVE METABOLITES OF AROMATIC AMINES AND OF COMPOUNDS WHICH PRODUCE FORMALDEHYDE ON OXIDATIVE DEALKYLATION CONSISTING ESSENTIALLY OF THE STEPS OF: (1) COMBINING A FLUID STREAM COMPRISING A SUBSTRATECOFACTOR A PHOSPHATE BUFFER WITH A RAT LIVER HOMOGENATE COMPRISING OXIDATIVE MICROSOMAL ENZYMES, (2) DIVIDING THE RESULTING MIXTURE INTO A FIRST STREAM FOR DETERMING THE QUANTITY OF PROTEIN AND INTO A SECOND STREAM FOR METABOLIZING THE SUBSTRATE AND FOR DETERMINING THE QUANTITY OF METALBOLITE GENERATED DURING SUCH METABOLISM, (3) DILUTING SAID FIRST STREAM WITH PHOSPHATE BUFFER, (4) AERATING SAID DILUTED FIRST STREAM, (5) REACTING SAID AERATED FIRST STREAM WITH A COLOR FORMING REAGENT FOR PROTEIN, (6) COLORIMETRICALLY DETERMINING THE AMOUNT OF PROTEIN, (7) INTERMITTENTLY ADDING SMALL ALIQUOTS OF 100% OXYGEN TO SAID SECOND STREAM, (8) INCUBATING SAID OXYGENATED SECOND STREAM AT A CONTROLLED TEMPERATURE TO PROMOTE THE FORMATION OF METABOLITE BY ENZYME ACTION ON SAID SUBSTRATE, (9) DIALYZING SAID SECOND STREAM AGAINST PHOSPHATE BUFFER, AND (10) COLORIMETRICALLY DETERMINING THE CONCENTRATION OF METABOLITE AFTER REACTING THE DIALSATE WITH A COLOR FORMING REAGENT FOR SAID METABOLITE.
US00281908A 1972-08-18 1972-08-18 Automated analysis of oxidative metabolites Expired - Lifetime US3846243A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00281908A US3846243A (en) 1972-08-18 1972-08-18 Automated analysis of oxidative metabolites

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00281908A US3846243A (en) 1972-08-18 1972-08-18 Automated analysis of oxidative metabolites

Publications (1)

Publication Number Publication Date
US3846243A true US3846243A (en) 1974-11-05

Family

ID=23079276

Family Applications (1)

Application Number Title Priority Date Filing Date
US00281908A Expired - Lifetime US3846243A (en) 1972-08-18 1972-08-18 Automated analysis of oxidative metabolites

Country Status (1)

Country Link
US (1) US3846243A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981777A (en) * 1976-01-19 1976-09-21 Union Carbide Corporation Method and apparatus for testing materials for levels of agents inhibitory or toxic to microorganisms
CN104215752A (en) * 2013-05-28 2014-12-17 恩德莱斯和豪瑟尔测量及调节技术分析仪表两合公司 Apparatus for automated determining of at least two different process parameters

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981777A (en) * 1976-01-19 1976-09-21 Union Carbide Corporation Method and apparatus for testing materials for levels of agents inhibitory or toxic to microorganisms
CN104215752A (en) * 2013-05-28 2014-12-17 恩德莱斯和豪瑟尔测量及调节技术分析仪表两合公司 Apparatus for automated determining of at least two different process parameters
US10078077B2 (en) 2013-05-28 2018-09-18 Endress+Hauser Conducta Gmbh+Co. Kg Apparatus for automated determining of at least two different process parameters

Similar Documents

Publication Publication Date Title
Marsh et al. Adaptation of an alkaline phosphatase method for automatic colorimetric analysis
Lundquist The determination of ethyl alcohol in blood and tissues
US3932131A (en) Method and device (analysis machine) for simultaneous performance of a number of analyses, especially microanalyses, of standard type on chemical objects
CA1104928A (en) Oxidizing phenolic compounds in enzymatic immunoassay
US3979262A (en) Compositions and methods for the determination of oxidizing agents
CN112946255A (en) Reagent or kit for detecting magnetic particle chemiluminescence of sialorrhea liquefied sugar chain antigen and application of reagent or kit
US3846243A (en) Automated analysis of oxidative metabolites
US3014848A (en) Method of performing biological assays
JP3182527B2 (en) Chemiluminescence measurement method and kit
EP0431682B1 (en) Buffered wash composition, insolubilizing composition, test kits and method of use
Furner Automated analysis of oxidative metabolites
Smithson et al. A reliable method for immunocytochemical identification of Lucifer Yellow injected, peptide-containing mammalian central neurons
Stähelin A simple quantitative test for cytostatic agents using non-adhering cells in vitro
US4105408A (en) Urea assay
US3667915A (en) Colorimetric methods and compositions for determining iron in blood
Murrell et al. DETERMINATION OF GLUCOSE IN FISH BLOOD: A MODIFICATION OF THE FOLIN–MALMROS MICROPROCEDURE
US3672838A (en) Analytical method and apparatus using diffusion across a boundary between liquids
Tan et al. New method for determination of alkylating agents in biologic fluids
CN113030479B (en) Sample application solution for protein chip
Shaw et al. Continuous-flow fluoroimmunoassay of serum gentamicin, with automatic sample blank correction.
Furner Automated method for studying the hepatic metabolism of aniline, ethylmorphine or p-nitroanisole
Munck et al. [35] Methods for assessing kinetics of hormone effects on energy and transport mechanisms in cells in suspension
Rodriguez-Castellon et al. Evaluation of an automated glucose-oxidase procedure
Okamoto et al. Measurement of human serum erythropoietin by erythroid colony‐forming technique using fetal mouse liver cells
Leech et al. A simple bedside method for the estimation of blood sugar